A genetic test result can feel like a major fork in the road, especially when you are already carrying the emotional weight of trying to build a family. The question of PGT testing versus carrier screening is not about choosing the “better” test. These tests answer different questions, at different points in the fertility journey, and sometimes they are used together.
Carrier screening looks at the genetic makeup of prospective parents. Preimplantation genetic testing, or PGT, looks at embryos created through IVF. Understanding that distinction can make a complex decision feel more manageable and help you have a more focused conversation with your fertility specialist and genetic counselor.
What carrier screening looks for
Carrier screening is typically performed before pregnancy or early in pregnancy using a blood or saliva sample. It looks for genetic changes, also called variants, that a person can carry without having symptoms themselves.
Many inherited conditions follow an autosomal recessive pattern. This means a child is usually affected only if they inherit a nonworking copy of the same gene from both parents. If both partners are carriers for the same recessive condition, each pregnancy has a 25% chance of being affected. Examples may include conditions such as cystic fibrosis, spinal muscular atrophy, or certain blood disorders, depending on the panel used.
Carrier screening can also identify some X-linked conditions. In these cases, the implications may differ depending on which partner carries the genetic variant and the sex chromosomes inherited by the child.
A carrier result is not a diagnosis. It does not mean a person is unwell, nor does it mean they will definitely have an affected child. Most people carry at least one genetic variant. The result simply provides information that may be relevant when both partners’ results are considered together.
Screening can be especially helpful for couples with a known family history of a genetic condition, relatives with an unexplained inherited illness, a previous affected pregnancy, or ancestry associated with certain conditions. It can also be a reasonable part of preconception planning for people without a known family history, since many carriers have no reason to suspect they carry a genetic variant.
What PGT tests during IVF
PGT is performed as part of an IVF cycle. Eggs are collected, fertilized in the laboratory, and allowed to develop into embryos. At the appropriate stage, a small number of cells may be biopsied from the part of the embryo that is expected to form the placenta. The embryo is usually frozen while the sample is analyzed.
There are different forms of PGT, each designed for a specific purpose.
PGT-M is used for monogenic, or single-gene, conditions. It may be considered when one or both intended parents have a known genetic variant that could be passed on to a child. Before an IVF cycle, the laboratory develops a test specifically for the family’s known condition.
PGT-SR is used when a parent has a known structural chromosome rearrangement, such as a balanced translocation. A person with a balanced rearrangement may be healthy but may have a higher chance of producing embryos with unbalanced chromosome material. This can contribute to infertility, miscarriage, or an affected pregnancy.
PGT-A assesses whether an embryo has the expected number of chromosomes. It is often discussed for patients of advanced maternal age, those with recurrent pregnancy loss, or those who have experienced unsuccessful IVF cycles. PGT-A is not designed to identify whether parents carry inherited single-gene conditions.
This distinction matters: PGT-A and carrier screening are not interchangeable. A chromosomally screened embryo may still be at risk for a single-gene condition if both parents carry the relevant variant. Likewise, a reassuring carrier screening result does not tell us whether an individual embryo has the expected chromosome number.
PGT testing versus carrier screening: the practical difference
Carrier screening helps answer: Could we be at risk of having a child with a particular inherited condition? PGT helps answer: Among the embryos created through this IVF cycle, which embryos appear not to have the specific genetic or chromosomal finding being tested for?
The timing is equally important. Carrier screening can be done before trying to conceive naturally, before fertility treatment, or during pregnancy. PGT can only be performed after embryos have been created through IVF.
If carrier screening shows that both partners carry the same recessive condition, there are several possible next steps. Some couples may continue trying to conceive and consider prenatal diagnostic testing during pregnancy. Others may choose IVF with PGT-M to reduce the chance of transferring an embryo affected by the known condition. Some may consider donor eggs, donor sperm, or other family-building options. There is no single right choice. The best path depends on medical circumstances, personal values, timing, financial considerations, and how much uncertainty a couple feels able to carry.
When both tests may be part of one plan
For some families, carrier screening is the first step that identifies a risk and leads to a discussion about PGT-M. For others, a known family condition has already been identified, and PGT-M planning begins before IVF.
Consider a couple who learn through carrier screening that they both carry a variant associated with the same recessive condition. They may have no symptoms and no known family history. Their specialist may recommend genetic counseling to explain the condition, confirm the result where appropriate, and discuss whether IVF with PGT-M fits their goals.
In another situation, a patient may be considering IVF because of tubal factors, male-factor infertility, or age-related fertility concerns. Carrier screening may still be useful before treatment, while PGT-A may be discussed separately based on embryo history and clinical context. One test does not automatically mean the other is needed.
Important limitations to understand
Genetic testing provides valuable information, but it cannot promise a healthy baby or guarantee a successful pregnancy. Carrier screening panels do not test for every possible genetic condition, and a negative result reduces risk rather than eliminating it.
PGT also has limitations. Results are based on cells sampled from the embryo, and embryos can occasionally contain cells with different genetic findings, a phenomenon called mosaicism. Not every embryo will be suitable for biopsy, and not every embryo will receive a result. A result indicating that an embryo is unaffected or chromosomally suitable does not assess every medical, developmental, or genetic condition.
For these reasons, prenatal screening and, in some circumstances, diagnostic testing such as chorionic villus sampling or amniocentesis may still be discussed after a PGT pregnancy. Diagnostic testing during pregnancy is a separate decision, and genetic counseling can help clarify its benefits and limitations.
How to decide what is appropriate for you
The most useful starting point is a detailed review of your medical and family history. Your fertility specialist may ask about prior miscarriages, stillbirths, infertility, previous children with health concerns, known genetic diagnoses, and chromosome results from prior pregnancies. If available, records from affected relatives can be particularly helpful when planning PGT-M or PGT-SR.
It is also worth considering your reproductive timeline. Carrier screening before pregnancy can give you more time to understand your options without the added pressure of an ongoing pregnancy or an imminent IVF cycle. However, it is never “too late” to ask for genetic guidance. Even when fertility treatment needs to move forward efficiently, the testing plan can be tailored to what is clinically meaningful for you.
At IVcare Fertility, these decisions are approached as part of an individualized fertility plan, with clear explanations of what each test can and cannot tell you. The goal is not to overwhelm you with more information. It is to help you make a choice grounded in sound medical guidance and aligned with the future you hope to create.
If genetic testing is on your mind, bring your questions, family history, and any previous test reports to a consultation. A thoughtful conversation now can offer clarity, protect your options, and make space for a new beginning built on informed hope.
